As seen on:
As seen on:
Latest Articles
How reinvesting dividends creates compounding growth, turns steady payouts into accelerating wealth, and why patient investors benefit most over time.
Unlock Asia’s next growth wave with these 3 healthcare stocks.
The government’s equity stimulus could reshape market sentiment, but its impact on dividends for retail investors deserves closer scrutiny.
Buried under all that market noise, this high-yield stock may offer steady income and upside.
The Smart Reads of the Year brings together the stories that defined 2025. From blue-chip compounding and CPF-beating dividends to REITs built for income and overlooked small caps with tailwinds, these were the ideas that mattered beyond market noise.
A quiet SGX holiday week saw a surprise REIT takeover bid, debt relief for Manulife US REIT, and NVIDIA’s largest-ever US$20 billion AI acquisition.
Popular
Is there any upside left for Singtel’s share price?
With stocks peaking and Fed cuts ahead, learn what lower interest rates could mean for investors.
If your purpose is to filter out dependable blue-chip stocks to include in your portfolio, these four deserve your attention.
If the business is performing well, why did the stock prices fall?
Stocks
Sembcorp and Seatrium reward shareholders with higher dividends as both Singaporean giants report resilient FY2025 earnings and positive cash flow.
UMS and AEM both ride the semiconductor cycle, but their business models, customer exposure, and growth prospects differ — which offers stronger long-term upside?
Grow your 2026 ang pow with three resilient Singapore blue-chip stocks for future growth.
Three Singapore market leaders demonstrate resilience through record revenues, digital healthcare pivots, and robust dividend payouts.